SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Immunex

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: aknahow who wrote (643)12/19/2001 8:01:54 AM
From: LemurHouse  Read Replies (1) of 656
 
<<<Why is the 44.50 tax free? Not saying that's not true but just wondering why it would be so. Was unable to find any reference on the Amgen site, that this part of the transaction could be tax free. TIA >>>

I'm sure you realize this, but I should point out that its $4.50 cash, not $44.50.

Here's the language that was taken from the transaction summary on the website. All of the early announcements made a point of stating that its a tax-free transaction.

Quote

Structure
Tax-free reorganization (Immunex shareholders will not be taxed to the extent that they exchange their Immunex stock for Amgen stock)

Terms
Immunex shareholders receive 0.44 shares of Amgen common stock and cash of $4.50 for each Immunex share

End Quote

All of this can be found at:
amgen.acquisitioninformation.com
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext